GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,555,000 | +12.9% | 115,000 | -8.0% | 3.65% | +14.1% |
| Q4 2017 | $4,919,000 | -36.6% | 125,000 | -50.0% | 3.20% | +49.7% |
| Q3 2017 | $7,762,000 | +62.2% | 250,000 | +42.9% | 2.14% | -20.9% |
| Q2 2017 | $4,786,000 | -35.1% | 175,000 | -12.5% | 2.71% | -25.8% |
| Q1 2017 | $7,370,000 | +191.4% | 200,000 | +14.3% | 3.64% | +141.1% |
| Q4 2016 | $2,529,000 | -83.1% | 175,000 | -73.1% | 1.51% | -43.4% |
| Q3 2016 | $14,982,000 | +201.0% | 650,000 | +116.7% | 2.67% | +31.9% |
| Q2 2016 | $4,977,000 | +25.5% | 300,000 | +20.0% | 2.02% | +39.4% |
| Q1 2016 | $3,965,000 | +11.5% | 250,000 | +127.3% | 1.45% | +24.2% |
| Q4 2015 | $3,556,000 | +29.8% | 110,000 | +69.2% | 1.17% | +8.5% |
| Q3 2015 | $2,740,000 | – | 65,000 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |